These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 21792529)

  • 21. Evaluation of newer treatment interventions for psychotic depression.
    O'Neal BL; Smith CL; Trivedi M
    Curr Psychiatry Rep; 2000 Aug; 2(4):305-9. PubMed ID: 11122973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic syndrome in patients with psychotic disorders: diagnostic issues, comorbidity and side effects of antipsychotics.
    Kozumplik O; Uzun S; Jakovljević M
    Psychiatr Danub; 2010 Mar; 22(1):69-74. PubMed ID: 20305594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is there a role for antidepressant and antipsychotic pharmacogenetics in clinical practice in 2014?
    Mulsant BH
    Can J Psychiatry; 2014 Feb; 59(2):59-61. PubMed ID: 24881124
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic side effects of antipsychotic medication.
    Tschoner A; Engl J; Laimer M; Kaser S; Rettenbacher M; Fleischhacker WW; Patsch JR; Ebenbichler CF
    Int J Clin Pract; 2007 Aug; 61(8):1356-70. PubMed ID: 17627711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drugs and depression.
    Harris B
    Am J Nurs; 1986 Mar; 86(3):292-3. PubMed ID: 2869688
    [No Abstract]   [Full Text] [Related]  

  • 26. Abnormalities of glucose metabolism associated with atypical antipsychotic drugs.
    Newcomer JW
    J Clin Psychiatry; 2004; 65 Suppl 18():36-46. PubMed ID: 15600383
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Weight gain, dyslipidemia and altered parameters for metabolic syndrome on first episode psychotic patients after six-month follow-up.
    Attux C; Quintana MI; Chaves AC
    Braz J Psychiatry; 2007 Dec; 29(4):346-9. PubMed ID: 17992359
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 24-week, randomized, controlled trial of adjunctive sibutramine versus topiramate in the treatment of weight gain in overweight or obese patients with bipolar disorders.
    McElroy SL; Frye MA; Altshuler LL; Suppes T; Hellemann G; Black D; Mintz J; Kupka R; Nolen W; Leverich GS; Denicoff KD; Post RM; Keck PE
    Bipolar Disord; 2007 Jun; 9(4):426-34. PubMed ID: 17547588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prescribing patterns of antipsychotics in 13 French psychiatric hospitals].
    Bret P; Bret MC; Queuille E
    Encephale; 2009 Apr; 35(2):129-38. PubMed ID: 19393381
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Psychotropic drugs in general practice].
    Zimmer A
    Praxis (Bern 1994); 2014 Jun; 103(13):763-6. PubMed ID: 24938158
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Weight gain and glucose and lipid metabolism disturbances during antipsychotic medication: a review.
    Koponen H; Saari K; Savolainen M; Isohanni M
    Eur Arch Psychiatry Clin Neurosci; 2002 Dec; 252(6):294-8. PubMed ID: 12563538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An epidemiologic study of psychotropic medication and obesity-related chronic illnesses in older psychiatric patients.
    Kisely S; Cox M; Campbell LA; Cooke C; Gardner D
    Can J Psychiatry; 2009 Apr; 54(4):269-74. PubMed ID: 19321033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A naturalistic comparison of the long-term metabolic adverse effects of clozapine versus other antipsychotics for patients with psychotic illnesses.
    Kelly AC; Sheitman BB; Hamer RM; Rhyne DC; Reed RM; Graham KA; Rau SW; Gilmore JH; Perkins DO; Peebles SS; VanderZwaag CJ; Jarskog LF
    J Clin Psychopharmacol; 2014 Aug; 34(4):441-5. PubMed ID: 24943389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms.
    Jin H; Folsom D; Sasaki A; Mudaliar S; Henry R; Torres M; Golshan S; Glorioso DK; Jeste D
    Schizophr Res; 2011 Feb; 125(2-3):295-9. PubMed ID: 21093219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Brazilian Consensus on second-generation antipsychotics and metabolic disorders].
    Elkis H; Gama C; Suplicy H; Tambascia M; Bressan R; Lyra R; Cavalcante S; Minicucci W
    Braz J Psychiatry; 2008 Mar; 30(1):77-85. PubMed ID: 18373022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The emergency treatment of depression complicated by psychosis or agitation.
    Glick RL; Ghaemi SN
    J Clin Psychiatry; 2000; 61 Suppl 14():43-8. PubMed ID: 11154016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consensus development conference on antipsychotic drugs and obesity and diabetes.
    ; ; ;
    Obes Res; 2004 Feb; 12(2):362-8. PubMed ID: 14981231
    [No Abstract]   [Full Text] [Related]  

  • 39. [Psychotropic drug-induced myoclonus].
    Brogmus KE; Lesch A
    Psychiatr Prax; 1995 Mar; 22(2):77-9. PubMed ID: 7761544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bridging the gap from evidence to policy and practice: reducing the progression to metabolic syndrome for children and adolescents on antipsychotic medication.
    Eapen V; Shiers D; Curtis J
    Aust N Z J Psychiatry; 2013 May; 47(5):435-42. PubMed ID: 23047958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.